The challenge of Lyme disease: Tired of the Lyme wars

Netherlands Journal of Medicine

Volumn 69, Issue 3, 2011, Pages 98-100

  Kullberg, B J ^a   Berende, A ^a   van der Meer, J W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; DIAGNOSTIC PROCEDURE; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOPATHOGENESIS; LYME DISEASE; PRACTICE GUIDELINE; TREATMENT DURATION; TREATMENT FAILURE;

COGNITION DISORDERS; FATIGUE; HUMANS; LYME DISEASE; PAIN; SEROLOGIC TESTS;

EID: 79953703988     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (16)

1. Hofhuis A, van der Giessen JW, Borgsteede FH, Wielinga PR, Notermans DW, van Pelt W. Lyme borreliosis in the Netherlands: strong increase in GP consultations and hospital admissions in past 10 years. Euro Surveill. 2006;11:E0606222.
2. Coumou J, van der Poll T, Speelman P, Hovius JWR. Tired of Lyme borreliosis. Lyme borreliosis in the Netherlands. Neth J Med. 2011;69:101-11.
3. CBO Guideline 'Lyme borreliosis'. Utrecht: Dutch Institute for Health Care Improvement CBO2004. www. cbo.nl.
4. Burgers JS, van Everdingen JJ. Evidence-based guideline development in the Netherlands: the EBRO platform. Ned Tijdschr Geneeskd. 2004;148:2057-9.
5. Wormser GP, Ramanathan R, Nowakowski J, McKenna D, Holmgren D, Visintainer P, et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2003;138: 697-704.
6. Cerar D, Cerar T, Ruzic-Sabljic E, Wormser GP, Strle F. Subjective symptoms after treatment of early Lyme disease. Am J Med. 2010;123:79-86.
7. Pfister HW, Preac-Mursic V, Wilske B, Einhaupl KM. Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study. Arch Neurol. 1989; 46:1190-4.
8. Weber K, Preac-Mursic V, Neubert U, Thurmayr R, Herzer P, Wilske B, et al. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Ann N Y Acad Sci. 1988;539:324-45.
9. Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001;345:85-92.
10. Cameron D. Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial. Minerva Med 2008;99:489-96.
11. Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003;60:1923-30.
12. Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70:992-1003.
13. Dattwyler RJ, Wormser GP, Rush TJ, Finkel MF, Schoen RT, Grunwaldt E, et al. A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr. 2005;117:393-7.
14. Persistent Lyme Empiric Antibiotic Study Europe (PLEASE). Available from: http://clinicaltrials.gov/ct2/show/NCT01207739.
15. Ang CW, Notermans DW, Hommes M, Simoons-Smit AM, Herremans T. Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots. Eur J Clin Microbiol Infect Dis. 2011: Published online, 29-01-2011.
16. Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet. 2006;367: 46-55.